Drugs / Allogenic parathyroid cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05186883 | Mar 2022 → Dec 2023 | hypoparathyroidism | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenic parathyroid cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05186883 ↗ |
| Modality | Cell therapy | “using cultured allogenic parathyroid cells” NCT05186883 ↗ |